Hydroxychloroquine does not increase the risk of arrhythmia, a large study in Arthritis & Rheumatology has found. The study was precipitated by controversy surrounding hydroxychloroquine and a ...

New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that treating rheumatoid arthritis with hydroxychloroquine (HCQ) reduced the risk of ...

The mutagenic potential of hydroxychloroquine has not been evaluated. However, chloroquine has been shown to be a catalytic inhibitor of DNA repair enzymes (topoisomerase II) and to produce weak ...

Please provide your email address to receive an email when new articles are posted on . There were no significant differences in HAQ-DI or CHFS score change in patients treated with hydroxychloroquine ...

An already approved drug has shown promise in preventing rheumatoid arthritis in people with a pre-existing condition that progresses into RA in more than half of cases.